Spruce Biosciences SPRB
NASDAQ SPRB
$45.15 -0.85 (-1.85%)
At close: Oct 23, 2026 · 4:00 PM EDT

Spruce Biosciences (SPRB) Sale and Maturity of Investments (2022 - 2023)

Updated

Analysis

Spruce Biosciences (SPRB) Sale and Maturity of Investments (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Spruce Biosciences 124.29 Mn -85.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 9.30 Mn
Sep 30, 2023 14.00 Mn
Jun 30, 2023 22.00 Mn
Mar 31, 2023 22.37 Mn
Dec 31, 2022 17.50 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 35.50 Mn
Mar 31, 2022 3.50 Mn
API Access

Spruce Biosciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=SPRB&period=max&api_key=YOUR_API_KEY